Monday, December 30, 2013

Kappac Pharma

Replacements in S&P BSE Indices
Content
 Trading members of the Exchange are hereby informed that following changes shall be made in below mentioned index:

INDICES
Exclusion
Inclusion
EFFECTIVE FROM
NAME
CODE
NAME
CODE
NAME
FFF

S&P BSE 500
532545
Fresenius Kabi Oncology Ltd
506938
Kappac Pharma Ltd
1.0
03-Jan-14
S&P BSE MID CAP
532545
Fresenius Kabi Oncology Ltd
--
--
--
 03-Jan-14

Change in constituents is made on the basis of guidelines governing inclusion and exclusion of companies from S&P BSE Indices. A detailed stock selection criterion for the indices is available at www.bseindia.com

Print this post

No comments: